Epidemiology of autism

Lore & Background

The epidemiology of autism has evolved significantly since the 1980s, when the number of diagnosed children began to rise dramatically. This increase is at least partly due to changes in diagnostic practice, such as the introduction of U.S. special-education autism classification in 1994 and revisions to diagnostic criteria in the DSM. Whether true prevalence has increased remains unclear, and unidentified environmental risk factors cannot be ruled out. A 2022 systematic review found a median global prevalence of 1% in children, though this may underestimate rates in low- and middle-income countries.

Reader's Guide

The epidemiology of autism is significant because it tracks how common ASD is and how diagnostic practices affect reported numbers. The field has documented a sharp rise in diagnoses since the 1980s, with U.S. rates increasing 176% from 2000 to 2016. However, much of this increase is attributed to broader diagnostic criteria, improved awareness, and changes in classification rather than a true rise in incidence. The male-to-female ratio of 4.3:1 highlights a consistent sex difference, though gender diverse populations overlap disproportionately with ASD. Access to treatment remains uneven, with 36% of affected children facing cost barriers. The field continues to debate whether prevalence is actually increasing and what role environmental factors may play.

Did You Know?

• A 2022 systematic review found a median global ASD prevalence of 1% in children, but this may underestimate rates in low- and middle-income countries.
• The male-to-female ratio in ASD diagnosis averages 4.3:1, not accounting for gender diverse populations, which overlap disproportionately with ASD.
• In the U.S., the rate of diagnosed autism increased 176% from 2000 (1 in 150) to 2016 (1 in 54).
• Barriers to care for children with ASD are documented, but no single percentage for difficulty affording care or remaining untreated is consistently cited in major epidemiological reviews.